![John Montana](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Montana
Directeur Général chez
Oxitope Pharma BV
Profil
John Montana is currently a Non-Executive Director at Metrion Biosciences Ltd., a Director, Chief Executive & Operating Officer at Oxitope Pharma BV, and an Operating Partner at Forbion Capital Partners Management Holding BV.
Previously, he held positions as a Director & Chief Scientific Officer at Pulmagen Therapeutics (Synergy) Ltd., Vice President-Integrated Drug Discovery at Charles River Laboratories International, Inc., Principal at Chiroscience Group Plc, Principal at Paradigm Therapeutics Ltd., and Principal at Glaxo, Inc. Dr. Montana obtained his undergraduate degree from The University of Manchester in 1983 and his doctorate degree from the University of East Anglia in 1987.
Postes actifs de John Montana
| Sociétés | Poste | Début |
|---|---|---|
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Engages in research and development of ion channel drugs | Directeur/Membre du Conseil | 09/02/2021 |
Oxitope Pharma BV
 Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Manufactures medicines for the treatment of inflammatory and cardiovascular diseases | Directeur Général | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 01/01/2020 |
Anciens postes connus de John Montana
| Sociétés | Poste | Fin |
|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Corporate Officer/Principal | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Chiroscience Group Plc
 Chiroscience Group Plc Miscellaneous Commercial ServicesCommercial Services Research based pharmaceutical group | Corporate Officer/Principal | - |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Directeur Technique/Scientifique/R&D | - |
Formation de John Montana
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiroscience Group Plc
Chiroscience Group Plc Miscellaneous Commercial ServicesCommercial Services Research based pharmaceutical group | Commercial Services |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Commercial Services |
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Glaxo, Inc. | |
Metrion Biosciences Ltd.
Metrion Biosciences Ltd. BiotechnologyHealth Technology Engages in research and development of ion channel drugs | Health Technology |
Oxitope Pharma BV
Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Manufactures medicines for the treatment of inflammatory and cardiovascular diseases | Health Technology |
